These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1185 related articles for article (PubMed ID: 26341056)

  • 1. Targeted therapeutic delivery using engineered exosomes and its applications in cardiovascular diseases.
    Xitong D; Xiaorong Z
    Gene; 2016 Jan; 575(2 Pt 2):377-384. PubMed ID: 26341056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological characteristics of exosomes and genetically engineered exosomes for the targeted delivery of therapeutic agents.
    Lin Y; Lu Y; Li X
    J Drug Target; 2020 Feb; 28(2):129-141. PubMed ID: 31280623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomes: Therapy delivery tools and biomarkers of diseases.
    Barile L; Vassalli G
    Pharmacol Ther; 2017 Jun; 174():63-78. PubMed ID: 28202367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
    Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and Roles of Exosomes in Cardiovascular Disease.
    Zhang Y; Hu YW; Zheng L; Wang Q
    DNA Cell Biol; 2017 Mar; 36(3):202-211. PubMed ID: 28112546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes as a Drug Delivery System in Cancer Therapy: Potential and Challenges.
    Kibria G; Ramos EK; Wan Y; Gius DR; Liu H
    Mol Pharm; 2018 Sep; 15(9):3625-3633. PubMed ID: 29771531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomes and the kidney: blaming the messenger.
    Fang DY; King HW; Li JY; Gleadle JM
    Nephrology (Carlton); 2013 Jan; 18(1):1-10. PubMed ID: 23113949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization of exosome-targeting peptides via engineered glycosylation.
    Hung ME; Leonard JN
    J Biol Chem; 2015 Mar; 290(13):8166-72. PubMed ID: 25657008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes: a role for naturally occurring nanovesicles in cancer growth, diagnosis and treatment.
    Srivastava A; Filant J; Moxley KM; Sood A; McMeekin S; Ramesh R
    Curr Gene Ther; 2015; 15(2):182-92. PubMed ID: 25537774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of exosome surface display technology in living human cells.
    Stickney Z; Losacco J; McDevitt S; Zhang Z; Lu B
    Biochem Biophys Res Commun; 2016 Mar; 472(1):53-9. PubMed ID: 26902116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive review on the composition, biogenesis, purification, and multifunctional role of exosome as delivery vehicles for cancer therapy.
    Li J; Zhang Y; Dong PY; Yang GM; Gurunathan S
    Biomed Pharmacother; 2023 Sep; 165():115087. PubMed ID: 37392659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologic function and therapeutic potential of exosomes in cardiovascular disease.
    Ailawadi S; Wang X; Gu H; Fan GC
    Biochim Biophys Acta; 2015 Jan; 1852(1):1-11. PubMed ID: 25463630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted exosome-based nanoplatform for new-generation therapeutic strategies.
    Yin W; Ma H; Qu Y; Wang S; Zhao R; Yang Y; Guo ZN
    Biomed Mater; 2024 Mar; 19(3):. PubMed ID: 38471163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Evolution of Ligands by Exosome Enrichment: A Proof-of-Concept Study for Exosome-Based Targeting Peptide Screening.
    Liu X; Yang X; Sun W; Wu Q; Song Y; Yuan L; Yang G
    Adv Biosyst; 2019 Feb; 3(2):e1800275. PubMed ID: 32627374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possibility of Exosome-Based Therapeutics and Challenges in Production of Exosomes Eligible for Therapeutic Application.
    Yamashita T; Takahashi Y; Takakura Y
    Biol Pharm Bull; 2018; 41(6):835-842. PubMed ID: 29863072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosome-Mediated Targeted Delivery of miRNAs.
    Ohno S; Kuroda M
    Methods Mol Biol; 2016; 1448():261-70. PubMed ID: 27317187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomal RNA as biomarkers and the therapeutic potential of exosome vectors.
    Lässer C
    Expert Opin Biol Ther; 2012 Jun; 12 Suppl 1():S189-97. PubMed ID: 22506888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvesicles and exosomes: new players in metabolic and cardiovascular disease.
    Lawson C; Vicencio JM; Yellon DM; Davidson SM
    J Endocrinol; 2016 Feb; 228(2):R57-71. PubMed ID: 26743452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodistribution of Exosomes and Engineering Strategies for Targeted Delivery of Therapeutic Exosomes.
    Choi H; Choi Y; Yim HY; Mirzaaghasi A; Yoo JK; Choi C
    Tissue Eng Regen Med; 2021 Aug; 18(4):499-511. PubMed ID: 34260047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A protocol for exosome isolation and characterization: evaluation of ultracentrifugation, density-gradient separation, and immunoaffinity capture methods.
    Greening DW; Xu R; Ji H; Tauro BJ; Simpson RJ
    Methods Mol Biol; 2015; 1295():179-209. PubMed ID: 25820723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.